The Cigna Group CI

FY2025 · ended Dec 31, 2025 · Revenue $274.90B, +11.2% YoY · Filed Feb 26, 2026

The Cigna Group (CI) files with the SEC under industry code 6324, Hospital & Medical Service Plans. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $274.9 billion and net income of $6.0 billion. As of Jun 30, 2026 it held $26.3 billion in cash and investments and $1.0 billion in total debt.

Revenue (TTM)
$282.38B
+7.8% vs year-ago TTM
Net income
$5.96B
Operating cash flow (TTM)
$10.28B
+94.2% vs year-ago TTM
Free cash flow
$8.44B
+160.2% vs prior year
EPS
$22.18
+83.0% vs prior year
Dividend per share (TTM)
$6.14
+5.5% vs year-ago TTM
Shares outstanding
263.53M
-3.7% vs prior year
Net cash
$25.29B
as of Jun 30, 2026
Operating margin
3.5%
FY 2026

Company profile

Industry
Hospital & Medical Service Plans (SIC 6324)
Listed as
CI (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bloomfield, CT
SEC filer status
Large accelerated filer
SEC CIK
1739940
Former names
Cigna Corp (until Feb 9, 2023); Halfmoon Parent, Inc. (until Dec 20, 2018)

Other Hospital & Medical Service Plans companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$274.9B
$247.1B
$195.3B
$180.5B
$174.1B
Operating income
$9.2B
$9.4B
$8.5B
$8.4B
$7.9B
Net income
$6.0B
—
—
—
—
Diluted EPS
$22.18
$12.12
$17.39
$21.41
$15.75
Operating cash flow
$9.6B
$10.4B
$11.8B
$8.7B
$7.2B
Total assets
$157.9B
$155.9B
$152.8B
$143.9B
$154.9B
Total liabilities
$116.0B
$114.6B
$106.4B
$99.1B
$107.7B
Stockholders' equity
$41.7B
$41.0B
$46.2B
$44.7B
$47.1B
Cash and investments
$27.2B
$23.3B
$26.7B
$23.1B
$24.4B
Total debt
$111.0M
$880.0M
$1.8B
$559.0M
$2.1B

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 9, 2026 Oct 6, 2026
8-K Current report
Regulation FD disclosure
Sep 30, 2026 Sep 30, 2026
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
8-K Current report
Regulation FD disclosure
May 13, 2026 May 13, 2026
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.